Home

aiškiai Kepkite JAV doleris idogen spotlight Struktūriškai Perlinis išsiskirti

BioInsights - Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)
BioInsights - Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)

Investors Home
Investors Home

Idogen AB (publ)
Idogen AB (publ)

Idogen files patent application for new tolerogenic cell therapy
Idogen files patent application for new tolerogenic cell therapy

Idogen AB (publ) Org nr
Idogen AB (publ) Org nr

Trading Direkt analyserar bolagen på Spotlight 2018-10-18: Plejd & Idogen - YouTube
Trading Direkt analyserar bolagen på Spotlight 2018-10-18: Plejd & Idogen - YouTube

Noteringar i veckan
Noteringar i veckan

Idogen appoints Anders Karlsson as new CEO - Idogen
Idogen appoints Anders Karlsson as new CEO - Idogen

biotech | pharma | diagnostics | devices
biotech | pharma | diagnostics | devices

Idogen's cell technology successfully advanced to large-scale production
Idogen's cell technology successfully advanced to large-scale production

Idogen AB | Aktiespararna
Idogen AB | Aktiespararna

Idogen's IDO 8 granted orphan drug designation in the USA - Idogen
Idogen's IDO 8 granted orphan drug designation in the USA - Idogen

Iodogen | C16H10Cl4N4O2 | ChemSpider
Iodogen | C16H10Cl4N4O2 | ChemSpider

Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community

Idogen - Crunchbase Company Profile & Funding
Idogen - Crunchbase Company Profile & Funding

Idogen AB Delårsrapport Januari–September 2019 | Tanalys
Idogen AB Delårsrapport Januari–September 2019 | Tanalys

Idogen AB publicerar Årsredovisning för 2018
Idogen AB publicerar Årsredovisning för 2018

biotech | pharma | diagnostics | devices
biotech | pharma | diagnostics | devices

niklas wallett - Idogen
niklas wallett - Idogen

Idogen's Historical Milestones - Idogen
Idogen's Historical Milestones - Idogen

Idogen will be listed on Nasdaq First North Growth Market on June 4, 2020
Idogen will be listed on Nasdaq First North Growth Market on June 4, 2020

Idogen AB Interim report Idogen AB Interim report
Idogen AB Interim report Idogen AB Interim report

Nyemission: Idogen förbereder för fas I/IIa-studie Idogen är ett svenskt bioteknikbolag baserat i Lund. Bolaget utvecklar tolerogena cellterapier som gör det möjligt att undvika en oönskad aktivering av kroppens immunsystem. Cellterapin baseras
Nyemission: Idogen förbereder för fas I/IIa-studie Idogen är ett svenskt bioteknikbolag baserat i Lund. Bolaget utvecklar tolerogena cellterapier som gör det möjligt att undvika en oönskad aktivering av kroppens immunsystem. Cellterapin baseras

biotech | pharma | diagnostics | devices
biotech | pharma | diagnostics | devices

Idogen AB Year-end report
Idogen AB Year-end report